Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Bingham Canyon Corp (BGHM)

Bingham Canyon Corp (BGHM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade BGHM with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3100 +48.39%
on 05/11/18
0.5000 -8.00%
on 05/01/18
-0.0400 (-8.00%)
since 04/13/18
3-Month
0.3100 +48.39%
on 05/11/18
0.5200 -11.54%
on 03/06/18
-0.0600 (-11.54%)
since 02/20/18
52-Week
0.3100 +48.39%
on 05/11/18
2.0000 -77.00%
on 07/06/17
-1.3900 (-75.14%)
since 05/15/17

Most Recent Stories

More News
MindMed Developing IP For Personalized Psychedelic Assisted Therapies

MindMed, in collaboration with the University Hospital Basel, has filed two separate patent applications for technologies to screen and optimize the dosing of MDMA and LSD

MMEDF : 0.8700 (-8.14%)
BGHM : 0.4600 (+12.20%)
Phase 2 Clinical Trial of LSD for "Suicide Headaches" Begins Treating Patients

MindMed Is Collaborating on a Phase 2 Clinical Trial of LSD For Cluster Headaches with University Hospital Basel's Liechti Lab

MMEDF : 0.8700 (-8.14%)
BGHM : 0.4600 (+12.20%)
Psychedelic Drugs Could Potentially Treat Impending Post-lockdown Mental Health Epidemic

, /PRNewswire/ --  Trials are already underway testing the use of psychedelics such as psilocybin, LSD, ketamine, ecstasy and other currently scheduled drugs to predicted to hit after the lockdown...

JNJ : 143.15 (-0.57%)
SHRM.CN : 0.890 (+3.49%)
SHRMF : 0.3652 (-6.36%)
LLY : 131.90 (-6.92%)
NUMI.VN : 0.465 (-7.00%)
LKYSD : 0.3330 (+17.54%)
MMEDF : 0.8700 (-8.14%)
BGHM : 0.4600 (+12.20%)

Key Turning Points

2nd Resistance Point 0.5000
1st Resistance Point 0.4800
Last Price 0.4600
1st Support Level 0.4400
2nd Support Level 0.4200

See More

52-Week High 2.0000
Fibonacci 61.8% 1.3544
Fibonacci 50% 1.1550
Fibonacci 38.2% 0.9556
Last Price 0.4600
52-Week Low 0.3100

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar